BioLineRx (BLRX) Tops Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts BLRX Hot Sheet
Join SI Premium – FREE
BioLineRx (NASDAQ: BLRX) reported Q2 EPS of $0.00, $0.14 better than the analyst estimate of ($0.14). Revenue for the quarter came in at $5.39 million versus the consensus estimate of $2.94 million.
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freedom Broker Downgrades HF Sinclair (DINO) to Sell
- Veralto Corporation (VLTO) Tops Q2 EPS by 19c ; Offers Guidance
- Rocky Brands (RCKY) Tops Q2 EPS by 135c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
